Leniolisib
Other Primary Immunodeficiencies (PIDs) with immune dysregulation
Not SpecifiedClinical Development
Key Facts
Indication
Other Primary Immunodeficiencies (PIDs) with immune dysregulation
Phase
Not Specified
Status
Clinical Development
Company
About Pharming Group
Pharming Group is a commercial-stage rare disease biopharmaceutical company with a mission to transform the lives of underserved patients. The company leverages its proven clinical development, supply chain, and commercial infrastructure to grow its existing portfolio and invest in long-term pipeline expansion. With a dual listing on Euronext Amsterdam (PHARM) and Nasdaq (PHAR), Pharming aims to become a leading global rare disease company through a combination of organic growth and strategic business development.
View full company profile